← Evidence map

ArticleRSC medicinal chemistry2023

A covalent fragment-based strategy targeting a novel cysteine to inhibit activity of mutant EGFR kinase.

Naoki Kuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 38107172